Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8772448
APP PUB NO 20080050841A1
SERIAL NO

11834557

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a peptide derived from an antigen recognized by autoantibodies, which peptide is reactive with autoimmune antibodies from a patient suffering from rheumatoid arthritis. The peptide according to the invention possesses a modified arginine residue. The invention also relates to antibodies against the peptide and a method of detecting autoimmune antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STICHTING VOOR DE TECHNISCHE WETENSCHAPPENVOLLENHOVENLAAN 661 JP UTRECHT 3527

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoet, Rene Michael Antonius Nijmegen, NL 5 17
Raats, Jozef Maria Hendrik Nijmegen, NL 22 29
Schellekens, Gerardus Antonius Den Bosch, NL 5 17
Van, Venrooij Waltherus Jacobus Wilhelmus Nijmegen, NL 11 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 8, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00